Percheron Therapeutics (AU:PER) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Percheron Therapeutics Limited announced a change in the shareholding of its director, James Garner, who has acquired an additional 375,000 ordinary shares through participation in the company’s Share Purchase Plan. This acquisition raises Garner’s total holding to 1,375,000 shares, reflecting continued confidence in the company’s prospects.
For further insights into AU:PER stock, check out TipRanks’ Stock Analysis page.